Known targets — ChEMBL curated mechanism
CHRM1DRD2DRD3DRD4HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR2APDE3ASIGMAR1SLC9A3
The experimentally established mechanism targets of L-Lactic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| L-Lactic Acid SCHEMBL446197 | 0.97 | TP53 (0.44) | — | |
| L-Lactic Acid SCHEMBL5182015 | 0.97 | CA4 (0.44) | — | |
| L-Lactic Acid SCHEMBL446198 | 0.97 | TP53 (0.44) | — | |
| L-Lactic Acid SCHEMBL8930746 | 0.97 | TP53 (0.44) | — | |
| L-Lactic Acid SCHEMBL31753630 | 0.97 | — | — | |
| L-Lactic Acid SCHEMBL1333089 | 0.96 | — | — | |
| L-Lactic Acid SCHEMBL186171 | 0.96 | — | — | |
| L-Lactic Acid SCHEMBL1332699 | 0.96 | — | — | |
| L-Lactic Acid SCHEMBL7999572 | 0.96 | TP53 (0.50) | — | |
| L-Lactic Acid SCHEMBL4360 | 0.96 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4616840-A2 | COMPOSITIONS COMPRISING (BIO)-ALKANEDIOLS WITH ANTIMICROBIALS FOR PRODUCT PROTECTION | Symrise AG (DE) | 2025-09-17 | — | — | EP | disclosed |
| EP-4103288-B1 | COMPOSITIONS COMPRISING (BIO)-ALKANEDIOLS WITH ANTIMICROBIALS FOR PRODUCT PROTECTION | SYMRISE AG (DE) | 2025-07-30 | — | — | EP | disclosed |
| EP-4582079-A2 | COMPOSITIONS COMPRISING (BIO)-ALKANEDIOLS WITH ANTIMICROBIALS FOR PRODUCT PROTECTION | Symrise AG (DE) | 2025-07-09 | — | — | EP | disclosed |
| WO-2024177403-A1 | APOPTOSIS-INDUCED STEM CELLS, PRODUCTION METHOD THEREFOR, AND COMPOSITION CONTAINING SAME FOR PREVENTING OR TREATING INFLAMMATORY OR RENAL DISEASES | 의료법인 성광의료재단 | 2024-08-29 | — | — | WO | disclosed |
| EP-4397298-A2 | COMPOSITIONS COMPRISING ANTIMICROBIALS AND (BIO)-ALKANEDIOLS FOR SKIN PROTECTION | Symrise AG (DE) | 2024-07-10 | — | — | EP | disclosed |
| US-20230364027-A1 | Compositions Comprising (Bio)-Alkanediols with Antimicrobials for Product Protection | AG, SYMRISE (US) | 2023-11-16 | — | — | US | disclosed |
| US-20230167428-A1 | A MODIFIED BACTERIAL HYALURONIDASE POLYPEPTIDE, PRODUCTION PROCESS, PHARMACEUTICAL COMPOSITIONS AND THEIR USES | PHARMACT HOLDING AG (CH) | 2023-06-01 | — | — | US | disclosed |
| WO-2023067008-A1 | A PRODUCTION OF A PURIFIED MODIFIED BACTERIAL HYALURONIDASE POLYPEPTIDE, PHARMACEUTICAL COMPOSITIONS AND THEIR USES | PHARMACT HOLDING AG (CH) | 2023-04-27 | — | — | WO | disclosed |
| EP-4139448-A1 | A MODIFIED BACTERIAL HYALURONIDASE POLYPEPTIDE, PRODUCTION PROCESS, PHARMACEUTICAL COMPOSITIONS AND THEIR USES | Pharmact Holding AG (CH) | 2023-03-01 | — | — | EP | disclosed |
| CN-115702242-A | Modified bacterial hyaluronidase polypeptide, production method, pharmaceutical composition and application thereof | 医药控股公司 | 2023-02-14 | — | — | CN | disclosed |
| WO-2013153192-A1 | COMPOUNDS WHICH INHIBIT NEURONAL EXOCYTOSIS (III) | LIPOTEC, S.A. (ES) | 2013-10-17 | — | — | WO | disclosed |
| US-5443848-A | Administering certain ratios of sodium chloride and sodium acetate; treating hemorrhagic shock | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1995-08-22 | — | — | US | disclosed |
| US-5294649-A | Hardening agent of magnesioum hydroxide or lightburned magnesium oxide and promoter of a nitrogen-containing heterocyclic compound | BORDEN, INC. (US) | 1994-03-15 | — | — | US | disclosed |
| US-5262495-A | Magnesium oxide or magnesium hydroxide hardeners to slow gelation | BORDEN, INC. (US) | 1993-11-16 | — | — | US | disclosed |
| US-5223554-A | Comprising anions of cyanate, formate, hypophosphite, nitrate, phosphite and sulfamate; used with magnesium hardening agent | BORDEN, INC. (US) | 1993-06-29 | — | — | US | disclosed |
| US-5214111-A | Comprising magnesium hydroxide hardener and retarder compounds, chelating agents; mixed with butyrolactone and water | BORDEN, INC. (US) | 1993-05-25 | — | — | US | disclosed |
| US-5214079-A | Magnesium oxide or hydroxide | BORDEN, INC. (US) | 1993-05-25 | — | — | US | disclosed |
| US-5182346-A | Magnesium oxide or hydroxide, chelating agent | BORDEN, INC. (US) | 1993-01-26 | — | — | US | disclosed |
| US-5145913-A | Decrease solubility of magnesium oxide or magnesium hydroxide hardener | BORDEN, INC. (US) | 1992-09-08 | — | — | US | disclosed |
| US-5096983-A | Magnesium oxide and and ester as hardeners, retarder to inhibit hardening | BORDEN, INC. (US) | 1992-03-17 | — | — | US | disclosed |